STAT

Goop promoted her as one of ‘our doctors.’ But Dr. Aviva Romm is concerned the site is becoming a caricature

Gwyneth Paltrow's wellness site, Goop, calls Dr. Aviva Romm one of "our doctors." But Romm says it needs medical review to avoid becoming a caricature.
Source: Layne Murdoch Jr./Getty Images for goop

The headline on Gwyneth Paltrow’s wellness site, Goop, looked straightforward enough: “Uncensored: A word from our doctors.”

It featured a defense of the alternative medical practices that Goop has promoted, such as tucking a jade egg in the vagina to enhance sexual pleasure. An attack on an OB-GYN who has publicly slammed Goop’s advice. And then, open letters from two doctors who have written for Goop in the past.

But one of those physicians, Dr. Aviva Romm, told STAT that she doesn’t see herself as Goop’s doctor at all. She hasn’t read most of the content on the site (which promotes things like goat’s milk cleanses, energy healing stickers, and “brain dust” to “align you with the mighty cosmic flow”). She can’t give it a scientific stamp of approval. And she’s wary of anyone who automatically endorses products or therapies simply because they’re branded as “natural.”

In fact, she said she’s advised Goop that if it wants to

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Drug Shortages, Medicare Spending On An Alzheimer’s Drug, And More
Medicare estimates a new Alzheimer’s drug could cost the program billions of dollars by next year — well beyond what Wall Street or the drug’s manufacturer project.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related Books & Audiobooks